Phenylpiracetam hydrazide
Clinical data | |
---|---|
Trade names | Phenylpiracetam hydrazide |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
Synonyms | Fonturacetam hydrazide |
CAS Number | 77472-71-0 |
PubChem (CID) | 4995664 |
ChemSpider | 4175636 |
UNII | 289199VKN4 |
Chemical and physical data | |
Formula | C12H15N3O2 |
Molar mass | 233.27 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
| |
| |
(what is this?) (verify) |
Phenylpiracetam hydrazide, also known as fonturacetam hydrazide,[1] is a designer drug that is a derivative of phenylpiracetam in which the amide group is replaced with a hydrazide group. It was first reported by a Russian research group in 1980 as part of a series of chemical compounds investigated as anticonvulsants.[2] In an electroshock test it was found to have an ED50 of 310 mg/kg.[2]
See also
References
- ↑ "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 63" (PDF). WHO Drug Information. 24 (1): 56. 2010. Retrieved 26 November 2015.
- 1 2 Glozman, O. M.; Morozov, I. S.; Zhmurenko, L. A.; Zagorevskii, V. A. (1980). "Synthesis and anticonvulsive activity of 4-phenyl-2-pyrrolidinone-1-acetic acid amides". Khimiko-Farmatsevticheskii Zhurnal (in Russian). 14 (11): 43–48.
This article is issued from Wikipedia - version of the 6/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.